By Jon Schiller The Coalition for Epidemic Preparedness Innovations is granting $4.3 million to Israel’s MigVax to advance development of COVID-19 vaccines suitable for use in low- and middle-income countries. The coalition, headquartered in Norway, also is funding a similar project at the University of Saskatchewan in Canada. Both projects aim to establish preclinical proof of concept for “variant-proof” vaccines […]

The post MigVax Gets Millions To Develop Variant-Proof Vaccine first appeared on The Florida Star | The Georgia Star.